ROYCE & ASSOCIATES LP - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,840,796
+34.8%
1,611,702
+55.0%
0.19%
+41.2%
Q2 2023$13,977,439
+36.9%
1,039,988
+68.8%
0.14%
+33.3%
Q1 2023$10,212,749
+3.2%
615,968
+15.8%
0.10%
-1.9%
Q4 2022$9,893,135
+17.1%
531,889
-19.2%
0.10%
+8.3%
Q3 2022$8,449,000
-42.6%
658,547
-68.6%
0.10%
-36.8%
Q2 2022$14,723,000
-21.5%
2,100,225
-7.1%
0.15%
-4.4%
Q1 2022$18,751,000
+7.2%
2,261,907
-12.5%
0.16%
+21.4%
Q4 2021$17,493,000
+9.8%
2,583,868
-14.1%
0.13%
+10.1%
Q3 2021$15,937,000
-9.8%
3,006,994
-2.2%
0.12%
-1.7%
Q2 2021$17,675,000
+18.0%
3,073,846
-5.4%
0.12%
+19.8%
Q1 2021$14,981,000
+86.5%
3,249,650
+35.1%
0.10%
+53.0%
Q4 2020$8,033,000
+51.5%
2,405,129
+34.7%
0.07%
+15.8%
Q3 2020$5,301,000
-12.4%
1,784,890
+36.3%
0.06%
-14.9%
Q2 2020$6,052,000
+144.1%
1,309,906
+103.4%
0.07%
+97.1%
Q1 2020$2,479,000
-15.3%
643,991
-17.5%
0.03%
+30.8%
Q4 2019$2,928,000780,7820.03%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders